Sunday, 5 September 2010

CHILD ABUSE: The Bone Disease of Preterm Birth: A Biomechanical Perspective

September 5, 2010
Department of Pediatrics, Wright State University School of Medicine, Dayton, OH 45404, U.S.A.
The bone disease of preterm birth has traditionally been explained by a decrease in bone formation from insufficient availability of calcium and phosphorus. However, there is emerging evidence that there is increased bone resorption in the bone disease of preterm birth, an observation that indicates some other explanation for this condition. The biomechanical model of postnatal bone formation states that, through a regulatory feedback system in the bone called the mechanostat, bone is able to respond to increased bone loading by increasing bone strength and to decreased bone loading by decreasing bone strength. It is suggested that this increased bone resorption in the markedly preterm infant compared with the term infant is secondary to decreased bone loading. Application of this model to the fetus and preterm infant suggests that intrauterine bone loading of the fetus from movement and kicking against the uterus is critical for normal fetal bone formation. The associated muscle growth from this activity also contributes to bone loading. The markedly preterm infant is deprived of much of this critical time period of intrauterine bone accretion, and bone formation occurs in the less favorable extrauterine environment, where there is significantly less bone loading.
Abbreviation: VLBW, very low birth weight
Infants who are born at 24, 25, and 26 wk of gestation now have a 50%, 70%, and 80% likelihood for survival, respectively
(1). This increasing survival rate of VLBW (VLBW = birth weight >(2). The specific cause of the bone disease of preterm birth must explain the observation that the rate of bone accretion for a fetus in an intrauterine environment is greater than that for a preterm infant in an extrauterine environment. Thus, the bone density of a full-term infant who is born at 40 wk of gestation is greater than that of a 12-wk-old preterm infant who is born at 28 wk of gestation (3).
It has been assumed that this difference in bone accretion rates in the intrauterine versus the extrauterine environment is from the difference in availability of calcium and phosphorus, the essential minerals needed for bone formation
(4). There is an exponential increase in bone formation during the last trimester during which approximately 80% of fetal bone is produced as the whole-body calcium increases from approximately 5 g at 24 wk of gestation to approximately 30 g at term, 40 wk of gestation (5). The peak accretion rate for bone occurs at approximately 35 wk of gestation, when the calcium accretion rate is approximately 150 mg/kg/d and the phosphorus accretion rate is approximately 75 mg/kg/d. It is interesting that there is a dramatic decrease in calcium accretion in the last 5 wk of pregnancy (6). For adequately meeting this large demand for calcium and phosphorus during this rapid period of bone formation during the last trimester, there is active transplacental transport of calcium and phosphorus from the mother to the fetus (7). It has been assumed that for normal extrauterine bone formation in a VLBW, preterm infant, similar daily requirements of calcium and phosphorus are needed. However, in the extrauterine environment, it is difficult to achieve this level of calcium and phosphorus delivery in the VLBW, preterm infant with enteral formulas or hyperalimentation (8). The cause of the bone disease in preterm birth has been ascribed to this particular issue of mineral substrate availability. Contributing factors to the bone disease of preterm birth include chronic illness, prolonged hyperalimentation, bronchopulmonary dysplasia, and the use of hypercalciuric drugs such as furosemide for treatment of bronchopulmonary dysplasia and methylxanthines for treatment of apnea and bradycardia, both of which increase calcium losses (8).
Back to Top Article Outline
Although the notion that decreased bone formation from diminished availability of calcium and phosphorus has traditionally been thought to be the primary cause of the bone disease of preterm birth, there are two observations that suggest otherwise and provide evidence of increased bone resorption in the bone disease of preterm birth. First, two separate groups have found urinary bone resorption markers in much greater concentration in preterm infants compared with term infants
(9, 10). Markers of bone resorption included collagen turnover compounds (hydroxyproline, type 1 collagen telopeptide), calcium, and phosphate. Beyers et al. (9) noted that preterm infants at expected full-term age had significantly greater urine excretion of calcium (2.9×), phosphate (4.3×), and hydroxyproline (3.7×) compared with normal term infants. Serum alkaline phosphatase was twice as great (411 U/L versus 206 U/L) in preterm infants at expected full-term age compared with the normal term infants. Moreover, radiologic evaluation showed increased endosteal resorption in the preterm infants. Mora et al. (10) found that preterm infants (average gestational age of 33 wk) had significantly higher blood levels of type 1 collagen telopeptide than term infants when both groups were studied at 4 wk of age. Using osteocalcin and procollagen type 1 carboxyterminal propeptide as indices of bone formation, these investigators found lower levels of bone formation in the preterm infants than the term infants. Others have also found an increased renal excretion of calcium and phosphorus in the preterm infant compared with the term infant (11).
Second, VLBW, preterm infants who are fed formula preparations with higher calcium and phosphorus content usually do not have an increased bone density
(12). If the bone disease of preterm birth were caused solely by calcium and phosphorus deficiency, then these two observations would not be expected. The totality of evidence points to some other factor or additional factor than just calcium and phosphorus availability as the basis for the bone disease of preterm birth.
What specific factor could explain this difference in bone resorption in the preterm versus term infant? In the past, a biochemical perspective has been taken in trying to understand human bone disease as shown in
Figure 1A. This approach has failed to provide adequately an understanding of the bone disease of preterm birth, because it ignores biomechanical factors. If a biomechanical perspective is taken, then the bone disease of preterm birth is easily understood as shown in Figure 1B. The answer to this conundrum is in the difference in bone loading of the skeletal system in the preterm infant compared with the term infant.
(13) proposed the mechanostat/mechanical loading model of postnatal bone formation, which states that the primary factor in the development of bone strength is the load (force) placed on the bone. The load causes a strain on the bone, which is transmitted to the mechanostat as an input signal. The mechanostat is a sensor within the bone that can evaluate the input of strain from a given load placed on the bone and then direct an appropriate output to the effector cells, osteoblasts and osteoclasts. Strain is the proportional change in length caused by a load and can be from compression, tension, or shearing loads. If a bone specimen is stretched by 1% of its length, then it is said to be undergoing a strain of 1%, or 10,000 microstrain. If a bone specimen is compressed by 0.1% of its original length so that it is now 99.9% of its original length, then it would be undergoing a strain of 1000 microstrain. Loads always cause strains even when they are small.
The mechanostat thus is the brain of the bone and functions as a feedback or regulatory system to keep bone strength commensurate with the loads placed on the bone. The mechanostat processes the strain input and compares it with preset, threshold levels of strain for increasing bone strength or decreasing bone strength. The mechanostat is then able to generate an appropriate output signal to effector cells to bring about the needed change in bone strength to align the strain within given limits. Effector cells are osteoblasts that produce bone and osteoclasts that resorb bone. If significantly increased loads that exceed the threshold for increasing bone strength are placed on a bone, then the mechanostat signals the effector cells to increase bone strength. If significantly decreased loads that exceed the threshold for decreasing bone strength are placed on a bone, then the mechanostat signals the effector cells to decrease bone strength. If the strain does not exceed either of these thresholds, then the effector cells operate at a status quo, or baseline, level of activity.
Osteoblast and osteoclast activity can change bone strength through either altering bone density or altering bone architecture through two distinctly different processes of bone physiology: bone modeling and bone remodeling. Both modeling and remodeling are processes that respond to bone loading through the mechanostat.
Modeling is the process by which bone is sculpted to the most advantageous geometry, both for bone strength and for appropriate attachment of muscles and tendons. As bone grows, some bone must be added to certain surfaces and some bone must be removed from other surfaces. The bone achieves this result through formation drifts and resorption drifts. Formation drifts influence osteoblasts to build up some bone surfaces, whereas resorption drifts influence osteoclasts to remove bone from some bone surfaces. Modeling results in changes of bone size or shape or of both and thus is a prominent process in bone development during fetal life and in childhood. In bone modeling, osteoblasts and osteoclasts function independent of each other, and each cell type responds to a certain preset modeling threshold within the mechanostat. Modeling almost always increases bone strength either by increasing bone mass or by favorably altering bone architecture.
Remodeling is the process whereby fatigued bone is efficiently removed and then replaced by new, intact bone by the sequential activity of osteoclasts to resorb the fatigued bone followed by osteoblasts to produce new bone. In bone remodeling, osteoblasts and osteoclasts act cooperatively in a coupled manner in a unit called a basic multicellular unit. This coordinated activity is also realized when a certain preset threshold of strain is sensed by the mechanostat.
There are two types of bone loading. The first is associated with the direct contact or impact of bone against another object, such as the increased load that the leg bones realize during running or from the resistance that a bone might experience such as the extremities realize in swimming. The second is associated with the active and passive load that the bone senses from the muscles attached to it. The muscles that attach to a bone exert a small but continuing load on the bone even when the muscle is not actively moving the bone. The loading of the skeletal system from attached muscles is critical in maintaining bone density. Weightlifters have greater bone density than nonweightlifters
(14). Children with chronic, neuromuscular diseases associated with muscle paralysis and muscle weakness have osteopenia and an increased risk for fracture (15).
Frost called this model the Utah paradigm, which is an ever-evolving paradigm that includes nutrient, hormonal, cellular, biochemical, and biomechanical factors
(16). The centerpiece of the Utah paradigm is the notion that bone strives to be a mechanically competent tissue through the operation of the mechanostat to sense strain from the loads placed on the bone and appropriately respond to these strains by increasing or decreasing bone strength. Others have also underscored the importance of mechanical considerations in skeletal health and disease (17-19).
According to the Utah paradigm, bones are formed in two distinct steps
(16). The first step is the embryogenesis of the skeletal system. Between 5 and 12 wk of gestation, multiple, specific genes direct condensations of mesenchyme to specific anatomic locations that are destined to become the precursor tissues of bone that will eventually chondrify and ossify (20). In a similar time period during the first trimester, other specific genes direct ventral and dorsal condensations of somitic mesoderm to become precursor tissues of skeletal muscle, and these will eventually attach to their appropriate bones. By 16 wk of gestation, the anatomy, anatomical relationships, and biologic machinery for adaptation of bones are in place. This state of bone is called the baseline conditions.
The second step of bone formation, beginning during the midportion of the second trimester, is the state of responsiveness of the skeletal system to genetically defined bone proteins and humoral mediators, nutrient considerations, and mechanical factors. Long bones grow both in length and in diameter. Linear bone growth of the long bones is determined primarily by specific genes through enchondral ossification. However, long bones assume their final, normal geometry, through the process of modeling. Modeling uses osteoblasts to form bone and osteoclasts to remove bone. Diametrical bone growth of long bones occurs through modeling in which osteoclasts remove bone from the endosteum and osteoblasts form bone along the periosteum. Flat bones, such as the scapula, pelvis, and skull, grow through intramembranous bone formation. Modeling that is responsive to bone loading occurs in enchondral and intramembranous bone formation in both the prenatal and postnatal periods. During the second and third trimesters, bone modeling also responds to increasing muscle forces. As the skeletal system of an individual ages, the adaptations for any given bone, which include growth, modeling, and remodeling, are added to the baseline conditions of the bone.
At the same time that bone modeling begins, fetal movement commences at approximately the 16th wk of gestation. Bone modeling is strongly influenced by bone loading, and bone loading during fetal life is determined primarily by fetal movement. Fetal movement leads to bone loading in three ways:1) the loading associated with the impact of the fetus, especially the extremities, against the uterus;2) the loading associated with the resistance against movement in the amniotic fluid; and 3) the loading associated with normal fetal muscle development, which is movement dependent.
The Utah paradigm, therefore, predicts that bone strength and, thus, bone density and bone architecture are directly related to fetal movement. In situations in which there is diminished fetal movement, decreased bone strength of the fetus and newborn is expected through changes in bone density and bone architecture. Three observations support the hypothesis that fetal movement determines fetal bone strength. First, previous work by Rodriguez et al.
(21) showed that infants with congenital neuromuscular disease in which there is both decreased fetal movement and decreased fetal muscle mass and function have osteopenia and decreased cortical bone thickness of long bones compared with controls. This observation suggests that there is diminished subperiosteal bone formation in infants with prenatal-onset neuromuscular disease. Second, Rodriguez et al. (22, 23) also described an experimental animal model called the fetal akinesia deformation sequence in which rat fetuses are pharmacologically immobilized with curare at 17 d of gestation (term gestation is 21 d). At birth, these curare-exposed rats have short umbilical cords and osteopenia compared with controls. Decreased fetal movement leads to a short umbilical cord (24). Third, diminished fetal movement and intrauterine confinement have been put forth as the underlying basis of temporary brittle bone disease (25, 26). This observation has suggested that prenatal bone loading in the form of fetal movement can influence postnatal bone strength during the first year of life and that infants who had significantly decreased fetal movement may be at risk for incurring fractures with physical forces that might not ordinarily cause a fracture, especially in the first 4 mo of life. Preterm birth is overrepresented in infants with temporary brittle bone disease (25).
That the fetus has a functioning musculoskeletal system by 16 wk of gestation sets the backdrop for the influence of biomechanics on fetal bone development after 16 wk of gestation. Whereas genetic information, hormonal influences, and nutrient considerations all influence bone physiology after 16 wk of gestation and into postnatal existence, it is biomechanical considerations that primarily determine ultimate bone strength, and these considerations have not been fully appreciated in the past in models of bone physiology before the Utah paradigm.
The extent of in utero bone loading will determine the ultimate skeletal strength of the fetus, especially during the last trimester, when there is rapid bone growth and bone mineralization. Fetal movement in the third trimester is the critical event that endows the newborn infant with normal bone loading and, thus, normal skeletal strength. The term infant who has an intact neuromuscular system realizes the full influence of this fetal movement on bone formation. The intrauterine loading of the fetal musculoskeletal system through fetal movement activates the mechanostat to increase bone strength through the process of modeling as shown in
Fig. 2. Fetal movement also promotes muscle growth, which contributes to bone loading and thus also influences bone modeling.
When an infant is born markedly preterm, however, the infant is deprived of much of this musculoskeletal bone loading in utero as also shown in
Fig. 2. After birth, the markedly preterm infant is often hypotonic and has a poverty of movements compared with the term infant (27). Attenuated bone loading in the VLBW, preterm infant leads to an input strain to the mechanostat that is lower compared with the term infant. Thus, there is also postnatal modulation of the mechanostat to increase resorption and decrease bone formation in the VLBW, preterm infant compared with the term infant. The markedly preterm, VLBW infant is, therefore, at a distinct biomechanical disadvantage in bone formation by losing weeks of meaningful intrauterine movement that promotes bone formation and replacing this period with that of an earlier-than-expected encounter with the extrauterine environment, which is less favorable for bone formation.
The rib fractures associated with preterm birth have the same underlying cause as the long bone fractures. The bone loading of ribs probably can occur from the following:1) fetal movement and kicking that likely is transmitted along the skeleton to the ribs;2) active or passive breathing, which would provide some bone loading through the ribs expanding in inspiration and contracting in expiration; and 3) the muscles attached to the ribs, which indirectly would get stronger with active breathing but probably would not get stronger if breathing were assisted by mechanical ventilation. Thus, a term infant who benefited from the loading of the skeleton during the entire 40 wk of gestation and who was actively breathing and not ventilator dependent during the newborn period would have stronger ribs than the 28-wk preterm infant who was deprived of 12 wk of exuberant intrauterine bone loading and who was on a ventilator for a prolonged period after birth because of respiratory problems. Rodriguez et al.
(21) found that the periosteal diameter of the fifth rib in infants with prenatal-onset neuromuscular disease was significantly lower than that of control infants, which indicates that prenatal bone loading does influence rib strength.
The recently published study by Moyer-Mileur et al.
(28) provides support that bone loading is important in bone formation of the preterm infant. They found that preterm infants who received daily physical therapy for an average period of approximately 27 d after birth had gains in forearm bone mineral density that were 75% greater than those in infants who did not receive physical therapy. This daily physical activity mimics the movement that this born, preterm infant would have had as an intrauterine fetus if the infant had not been born preterm.
The traditional, biochemical paradigm of bone biology adequately details the intricate relationships between calcium, phosphorous, and various other hormonal influences on their disposition, as shown in
Fig. 1A. However, the biochemical model does not consider the primary determinant of bone formation, bone loading. Only when biomechanical factors are considered in the context of the biochemical model of bone biology is there a complete picture of bone dynamics as shown in Figure 1B. This biomechanical model of perinatal bone formation suggests that mineral availability needs to be matched for the degree of bone loading on the skeletal system of the fetus/infant. Intrauterine movement of the fetus in the last trimester is much greater than the movement of the newborn infant, term or preterm, in the immediate postnatal period. The intrauterine environment is unique and well-suited for promoting bone loading of the fetal musculoskeleton, for the fetus is buoyed in amniotic fluid, which allows for bouncing and kicking against the uterine wall. This type of environment cannot be duplicated once the infant is born; thus, the VLBW, preterm infant loses this critical period of intrauterine bone formation.
This model predicts that the amount of mineral needed for bone formation would be less once the infant is born, because of the change in the quality and quantity of movement, yet it has been the goal to attain in the VLBW preterm infant mineral availability that is comparable to the in utero delivery of calcium and phosphorus. The conventional wisdom of trying to achieve the same levels of mineral availability in the immediate postnatal period should be reevaluated for it may not be physiologically adaptive to the level of bone loading. The lower concentrations of calcium and phosphorus in breast milk may be giving us this message.
The biomechanical model of bone formation also explains the observations that chronic illness, bronchopulmonary dysplasia, and hyperalimentation are associated with the bone disease of preterm birth. All of these are associated with relative immobilization compared with a healthy, term infant and therefore would lead to increased bone resorption. The decrease in calcium accretion between 35 and 40 wk of gestation also follows from the biomechanical paradigm, because there is a physiologic crowding of the fetus during this time, with a rapidly increasing fetal volume and decreasing amniotic fluid volume
This biomechanical paradigm has important therapeutic implications in the treatment of the bone disease of preterm birth. In addition to the amounts of calcium and phosphorus in the diet of the VLBW, preterm infant, attention should be given to the bone loading of these infants. Passive range-of-motion activities should be considered in these infants, the success of which has been demonstrated by Moyer-Mileur et al.
(28). The frequency of nephrocalcinosis, which is associated with VLBW infants, might be decreased with this approach, as it would increase bone accretion and thus decrease the amount of calcium presented to the kidney (30).
Fetal bone accretion is directly related to fetal movement. Although nutritional factors such as mineral availability may be contributing factors in the bone disease of preterm birth, this condition is best explained by the decreased quality and quantity of intrauterine and extrauterine movement of the VLBW, preterm infant compared with that of the term infant. Some of the problematic issues of the bone disease of preterm birth and rational therapeutic interventions for its treatment become readily understandable with a biomechanical perspective of this issue.

No comments:

Post a Comment